The blood plasma company Diag Human which is suing the Czech state for allegedly failing to protect its investment in the Czech Republic says the protracted court battle is not over. The company said on Monday it would appeal the verdict of a Czech arbitration court and take the case to a foreign court of law. The verdict of the arbitration court, delivered to both parties last week, is being interpreted differently. The Czech Health Ministry says it is a definitive verdict in the Czech Republic’s favour, meaning that following an appeal it will not have to pay the company eight billion crowns in compensation, while Diag Human claims that last week’s ruling upholds an earlier verdict according to which the Czech state will have to compensate the firm for a marred deal in the 1990s.
Friendly guide maps Prague ethnic eateries
Czech political parties clash over who should exploit lithium reserves
Thriving Prague hotels raising prices to previously unseen levels
Activists pour blood-red substance in Vltava to protest alleged ‘misuse’ of Mánes art gallery
Strong Czech economic growth surprises experts